Effects of screening for breast cancer on its age-incidence relationships and familial risk

International Journal of Cancer

Volumn 117, Issue 1, 2005, Pages 145-149

  Hemminki, Kari ^a,b   Bermejo, Justo Lorenzo ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Age incidence; Breast cancer; Familial risk; Mammographic screening

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FAMILIAL CANCER; FEMALE; FINLAND; FRANCE; GERMANY; HUMAN; MAMMOGRAPHY; NETHERLANDS; NORWAY; ONSET AGE; PRIORITY JOURNAL; SCREENING TEST; SISTER CHROMATID; SWEDEN; UNITED KINGDOM;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PILOT PROJECTS;

EID: 24344463435     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21149     Document Type: Article

References (19)

1. Anttila A, Pukkala E, Söderman B, Kallio M, Nieminen P, Hakama M. Effect of organized screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer 1999;83:59-65.
2. Stewart B, Kleihues P. World Cancer Report Lyon: IARC Press, 2003:351.
3. IARC. Breast cancer screening, vol. 7. Lyon: IARC Press, 2002.
4. Olsen AH, Jensen A, Njor SH, Villadsen E, Schwartz W, Vejborg I, Lynge E. Breast cancer incidence after the start of mammography screening in Denmark. Br J Cancer 2003;88:362-5.
5. Duffy SW, Tabar L, Vitak B, Yen MF, Warwick J, Smith RA, Chen HH. The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation. Ann Oncol 2003;14:1196-8.
6. Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. Bmj 2004;328:921-4.
7. Paci E, Warwick J, Falini P, Duffy SW. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen 2004;11:23-7.
8. Hemminki K, Rawal R, Lorenzo Bermejo J. Mammographic screening is dramatically changing age-incidence data for breast cancer. J Clin Oncol 2004;22:4652-3.
9. Hemminki K, Rawal R, Bermejo JL. Prostate cancer screening, changing age-specific incidence trends and implications on familial risk. Int J Cancer 2005;113:312-5.
10. Olsson S, Andersson I, Karlberg I, Bjurstam N, Frodis E, Hakansson S. Implementation of service screening with mammography in Sweden: from pilot study to nationwide programme. J Med Screen 2000;7:14-8.
11. Lynge E, Olsen AH, Fracheboud J, Patnick J. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prev 2003;12:213-22.
12. Sarkeala T, Anttila A, Forsman H, Luostarinen T, Saarenmaa I, Hakama M. Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. Eur J Cancer 2004;40:2116-25.
13. IARC. EUCAN, Cancer Incidence, Mortality and Prevalence in the European Union. Lyon: IARC Press, 1999.
14. Hemminki K, Li X, Plna K, Granström C, Vaittinen P. The nationwide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol 2001;40:772-7.
15. Hemminki K, Vaittinen P, Dong C, Easton D. Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 2001;84: 388-91.
16. Topo P, Klaukka T, Hemminki E, Uutela A. Use of hormone replacement therapy in 1976-89 by 45-64 year old Finnish women. J Epidemiol Community Health 1991;45:277-80.
17. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360:942-4.
18. ASCO. American Society for Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21:2397-406.
19. Lorenzo Bermejo J, Hemminki K. A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations. Ann Oncol 2005;16:322-9.